Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -47.88% this year. Over the last six months, there has been a stronger performance of -13.99%. The price of MIST fallen by 39.77% during the last 30 days period. For the last 5-days stocks have improved 16.04%.
Milestone Pharmaceuticals Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $2.75 on 12/31/24 and the lowest value was $0.63 on 04/09/25.
52-week price history of MIST Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Milestone Pharmaceuticals Inc’s current trading price is -55.27% away from its 52-week high, while its distance from the 52-week low is 96.67%. The stock’s price range during this period has varied between$0.63 and $2.75. The Milestone Pharmaceuticals Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.92 million for the day, a figure considerably lower than their average daily volume of 2.51 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Milestone Pharmaceuticals Inc (MIST) has experienced a quarterly decline of -37.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 65.63M and boasts a workforce of 33 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7559, with a change in price of -0.7700. Similarly, Milestone Pharmaceuticals Inc recorded 1,776,639 in trading volume during the last 100 days, posting a change of -38.50%.
MIST’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MIST stands at 4.17. Similarly, the long-term debt-to-equity ratio is also 4.12.
MIST Stock Stochastic Average
Milestone Pharmaceuticals Inc’s raw stochastic average for the past 50 days is presently 32.10%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 81.08%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 90.86% and 73.53%, respectively.
